Dexcom traded at $75.45 this Wednesday June 29th, increasing $0.75 or 1.00 percent since the previous trading session. Looking back, over the last four weeks, Dexcom gained 74.68 percent. Over the last 12 months, its price fell by 82.33 percent. Looking ahead, we forecast Dexcom to be priced at 75.58 by the end of this quarter and at 69.64 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
75.45
Daily Change
1.00%
Yearly
-82.33%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 256.49 7.41 2.97% -17.82%
Abbott 109.10 2.13 1.99% -5.89%
Align Technology 242.15 0.23 0.10% -60.37%
AtriCure 40.78 1.12 2.82% -48.59%
Avanos Medical Inc 27.18 0.49 1.84% -25.27%
Baxter International 65.81 0.56 0.86% -18.25%
Becton, Dickinson and Co. 249.34 4.81 1.97% 2.53%
Boston Scientific 37.80 0.30 0.80% -11.60%
Cooper Companies 317.71 3.63 1.16% -19.82%
Cardiovascular Systems 14.65 0.03 0.21% -65.65%
Dexcom 75.45 0.75 1.00% -82.33%
Edwards Lifesciences 96.03 1.30 1.37% -7.28%
Globus Medical 57.53 -0.02 -0.03% -25.80%
Hologic 70.35 0.57 0.82% 5.44%
Integra LifeSciences 55.85 1.39 2.55% -18.16%
Inogen 24.04 -0.38 -1.56% -63.11%
J&J 176.99 0.05 0.03% 7.44%
Masimo 136.11 -0.96 -0.70% -43.86%
Medtronic 90.42 1.22 1.37% -27.16%
Merit Medical Systems 54.58 0.81 1.51% -15.59%
NuVasive 49.98 0.36 0.73% -26.26%
Insulet 221.94 -4.27 -1.89% -19.15%
Roche Holding 319.65 2.10 0.66% -8.29%
Sientra 0.84 -0.04 -4.95% -89.48%
Stryker 199.43 1.63 0.82% -23.22%
Teleflex 256.83 3.57 1.41% -36.08%
Tandem Diabetes Care 60.19 -0.15 -0.25% -38.20%
West Pharmaceutical Services 299.52 3.06 1.03% -16.59%
Zimmer Biomet Holdings Inc 106.55 0.07 0.07% -33.75%

Indexes Price Day Year
USND 11178 -3.65 -0.03% -22.93%
US2000 1719 -19.47 -1.12% -25.59%
US500 3817 -2.72 -0.07% -11.18%
USNDX 11672 20.49 0.18% -19.81%

Dexcom
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.